Back to Search
WILLIAM ARONSON, MD
MD
Urology Physician
NPI: 1639194095Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
G64582(CA)
Research & Publications (20)
Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer.
PMID 11489728·Urology·2001
3-trial
Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention.
PMID 19376839·Evid Based Complement Alternat Med·2011
8-other
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
PMID 19522861·BJU Int·2010
4-observational
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
PMID 19524974·J Urol·2009
4-observational
Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group.
PMID 19549124·BJU Int·2009
4-observational
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?
PMID 19021608·BJU Int·2009
4-observational
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database.
PMID 18626507·Prostate Cancer Prostatic Dis·2009
4-observational
Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
PMID 19670453·Cancer·2009
8-other
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
PMID 19466946·BJU Int·2009
4-observational
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
PMID 19298411·BJU Int·2009
4-observational
Dietary intervention strategies to modulate prostate cancer risk and prognosis.
PMID 19300265·Curr Opin Urol·2009
6-review
Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence.
PMID 19395692·Am J Epidemiol·2009
8-other
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
PMID 18783735·Contemp Clin Trials·2009
4-observational
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.
PMID 19336564·Cancer Epidemiol Biomarkers Prev·2009
8-other
Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database.
PMID 19322137·Prostate Cancer Prostatic Dis·2009
8-other
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.
PMID 18790748·Mol Cancer Ther·2008
7-preclinical
The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database.
PMID 18778348·BJU Int·2008
4-observational
Obesity is a significant risk factor for prostate cancer at the time of biopsy.
PMID 18722650·Urology·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10833 LE CONTE AVE.
LOS ANGELES, CA 90095 - Phone
- (310) 303-6204
Quick Facts
- NPI
- 1639194095
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile